Author:
Olson Harry,Betton Graham,Stritar Jeffrey,Robinson Denise
Subject
Toxicology,General Medicine
Reference6 articles.
1. Success rates for new drugs entering clinical testing in the United States;DiMasi;Clin. Pharmacol. Ther.,1994
2. R&D philosophy and management in the leading pharmaceutical companies;Halliday;J. Pharm. Med.,1992
3. Target organ toxicity II;Heywood;Toxicol. Lett.,1983
4. Igarashi, T., 1994. The duration of toxicity studies required to support repeated dosing in clinical investigation — a toxicologist's opinion. In: Parkinson, C., McAuslane, N., Lumley, C., Walker, S.R. (Eds.), The Timing of Toxicological Studies to Support Clinical Trials. Kluwer, Boston, pp. 64–67.
5. Lumley, C., 1990. Clinical toxicity: could it have been predicted? Pre-marketing experience. In: Lumley, C.R., Walker, S.R. (Eds.), Animal Toxicity Studies: Their Relevance for Man. Quay, Lancaster, UK, pp. 57–67.
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献